赛升药业(300485.SZ)：子公司药品生产许可证变更

Core Viewpoint - Sai Sheng Pharmaceutical (300485.SZ) announced that its subsidiary, Shenyang Junyuan Pharmaceutical Co., Ltd., has recently obtained a Drug Manufacturing License from the Liaoning Provincial Drug Administration, with a change in the production responsible person from Li Li to Liu Huifeng, while other details remain unchanged [1] Company Summary - Sai Sheng Pharmaceutical's subsidiary, Shenyang Junyuan Pharmaceutical, has received a Drug Manufacturing License [1] - The change in the production responsible person is a key update, with Liu Huifeng taking over from Li Li [1] - Other aspects of the license remain unchanged, indicating stability in operations [1]